Genetic analysis

Cancer can have genetic causes. Genetic diagnostics allow early and specific identification of such cancer risks. At cell level mutations and other genetic abnormalities known to be associated with cancer are detected with suitable analysis methods. This genetic diagnosis is of great importance particularly for relatives of patients with certain types of cancer. Genetic diagnostics therefore allow early and specific preventative measures to be taken and make treatment optimisation possible through a precise classification of the cancer in question.

Prof. Dr Krainer is the director of the “Centre of Competence for Genetic Analysis” laboratory approved by the Ministry of Social Security and Generations. Here genetic diagnosis is carried out to determine a predisposition to or carrier status for hereditary breast cancer and colon cancer and supplemented with detailed consultations:

• Human genetic advising of cancer patients and their relatives with regard to predisposition to cancer
• Molecular genetic examinations (MLH1, MSH2) in patients with colon cancer and cancer of the womb
• Molecular genetic examinations (BRCA1, BRCA2) in patients with ovarian cancer and breast cancer
• Creating tailor-made preventative programmes taking into account genetic risk and cancer risk in general
• Molecular genetic examinations of tumours of relevance to diagnosis and treatment
• Psychological advising of cancer patients and patients at high risk of cancer
• Nutritional advice for cancer patients

Information about patients in whom a genetic analysis for breast and ovarian cancer should be carried out can be found in the following brochure:

  Folder – Hereditary breast and colon cancer (499.3 KB)

CCGA-Login for partnering physicians:
Competence Center for Genetic Analysis